Search - tctmd.com

Displaying 701 - 720 of 990

Sort: Relevancy | Date

News Daily News

Avoiding Gluten May Backfire in Terms of Coronary Risk in the General Population, Study Suggests

Todd Neale

May 11, 2017

News Features

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Michael O'Riordan

May 08, 2017

News Daily News

More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds

Todd Neale

May 05, 2017

News Features

Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe

Shelley Wood

May 05, 2017

News Daily News

Cardiac Intensive Care Units Face an Ever More Complex Patient Population

Caitlin E. Cox

April 28, 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2017

Shelley Wood

April 28, 2017

News Daily News

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

Michael O'Riordan

April 27, 2017

News Daily News

One in Five Acute MI Patients Drop Statins Within 2 Years

Michael O'Riordan

April 20, 2017

News Daily News

Physically Active Less Likely to Die After MI Than Sedentary Individuals

Michael O'Riordan

April 14, 2017

News Opinion Fellow Talk

The Left Main Debate: What Does it Mean for the Future of Intervention?

Tiffany Patterson, MBBS

April 12, 2017

News Daily News

Younger, Heavier, and Uninsured: Trends Point to Rising Risks in Acute MI, Ischemic Stroke Patients

Yael L. Maxwell

April 11, 2017

News Daily News

ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events

Michael O'Riordan

April 04, 2017

News Daily News

‘Constellation of Cardiovascular Stressors’ Puts Firefighters at Risk for MI

L.A. McKeown

April 03, 2017

News Conference News ACC 2017

High-Dose Atorvastatin Does Not Impact Cognition, but Small Changes Observed on Brain MRI

Michael O'Riordan

March 21, 2017

News Conference News ACC 2017

Going to Low LDL Levels With Evolocumab Does Not Affect Memory, Brain Function: EBBINGHAUS

Michael O'Riordan

March 19, 2017

News Conference News ACC 2017

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Michael O'Riordan

March 18, 2017

News Conference News ACC 2017

FFR-Guided Complete Revascularization Tops PCI of Culprit Artery Alone in Acute STEMI

Todd Neale

March 18, 2017

News Conference News ACC 2017

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Caitlin E. Cox

March 18, 2017

News Conference News ACC 2017

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

Michael O'Riordan

March 17, 2017

News Daily News

Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA

Michael O'Riordan

March 15, 2017

Advertisement

Avoiding Gluten May Backfire in Terms of Coronary Risk in the General Population, Study Suggests

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds

Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe

Cardiac Intensive Care Units Face an Ever More Complex Patient Population

TCTMD’s Top 10 Most Popular Stories for April 2017

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

One in Five Acute MI Patients Drop Statins Within 2 Years

Physically Active Less Likely to Die After MI Than Sedentary Individuals

The Left Main Debate: What Does it Mean for the Future of Intervention?

Younger, Heavier, and Uninsured: Trends Point to Rising Risks in Acute MI, Ischemic Stroke Patients

ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events

‘Constellation of Cardiovascular Stressors’ Puts Firefighters at Risk for MI

High-Dose Atorvastatin Does Not Impact Cognition, but Small Changes Observed on Brain MRI

Going to Low LDL Levels With Evolocumab Does Not Affect Memory, Brain Function: EBBINGHAUS

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

FFR-Guided Complete Revascularization Tops PCI of Culprit Artery Alone in Acute STEMI

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content